1. Home
  2. CCS vs KRSA Comparison

CCS vs KRSA Comparison

Compare CCS & KRSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

N/A

Current Price

$55.45

Market Cap

1.6B

ML Signal

N/A

Logo Korsana Biosciences Inc. Common Stock

KRSA

Korsana Biosciences Inc. Common Stock

N/A

Current Price

$30.86

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCS
KRSA
Founded
2000
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
CCS
KRSA
Price
$55.45
$30.86
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
★ $72.00
$44.00
AVG Volume (30 Days)
★ 260.2K
150.4K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 2.24%
N/A
EPS Growth
N/A
★ 8.26
EPS
★ 2.54
N/A
Revenue
★ $4,117,816,000.00
$2,074,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.43
N/A
P/E Ratio
$22.49
★ N/A
Revenue Growth
N/A
★ 3.70
52 Week Low
$47.28
$29.03
52 Week High
$76.00
$37.27

Technical Indicators

Market Signals
Indicator
CCS
KRSA
Relative Strength Index (RSI) 46.42 46.00
Support Level $52.94 $29.67
Resistance Level $55.40 $35.04
Average True Range (ATR) 2.61 2.19
MACD 0.31 0.01
Stochastic Oscillator 56.70 29.84

Price Performance

Historical Comparison
CCS
KRSA

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About KRSA Korsana Biosciences Inc. Common Stock

Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.

Share on Social Networks: